| Filed On | Filing |
|---|---|
| 29 Nov 2022 |
8-K/A: Financial Statements and Exhibits
Chemomab Therapeutics, Inc. (the “Company”) is pleased to offer you employment as Chief Medical Officer & VP, Drug Development on the following terms: |
| 12 Nov 2021 | 8-K/A: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure |
| 14 Apr 2021 | 8-K/A: Financial Statements and Exhibits |
| 19 Mar 2021 | 8-K/A: Financial Statements and Exhibits |
Loading...
